my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
19-03-2009: The former biotech company Profos AG situated in the Biopark in Regensburg has been acquired by new investors and starts from March 2009 as a new company Hyglos GmbH. The new holders of the company are investors coming from science and industry (Hyglos Invest GmbH and bioMérieux S.A.).
The focus of Hyglos GmbH is the production and distribution of products and services developed within the last years on the basis of the patented phage-protein technology. Several projects have achieved production level and additionally to the established product portfolio with the main segments “EndoLine” and “Food Diagnostics” further product launches are planned.
Contact / Request information
Request further information free of charge:
Watchlist
This is where you can add this news to your personal favourites
The former biotech company Profos AG situated in the Biopark in Regensburg has been acquired by new investors and starts from March 2009 as a new company Hyglos GmbH. The new holders of the company are investors coming from science and industry (Hyglos Invest GmbH and bioMérieux S.A.). The ... more
Profos AG achieves ISO 9001:2000 and EN ISO 13485:2003 certification
As of October 30, 2006, Profos AG has been certified according to ISO 9001:2000 and 13485, the internationally recognized quality management system standard developed by the International Organization for Standardization (ISO), for its Regensburg facilities of Research & Development, Produc ... more
Danisco Venture invests in Profos AG
Regensburg, Germany - Profos AG and Danisco Venture announced that they have agreed to an equity financing of several million euros, of which some are subject to milestones being met. Certain patent rights, which Danisco Venture has secured from third parties, have also been transferred to ... more
The former biotech company Profos AG situated in the Biopark in Regensburg has been acquired by new investors and starts from March 2009 as a new company Hyglos GmbH. The new holders of the company are investors coming from science and industry (Hyglos Invest GmbH and bioMérieux S.A.). The ... more
Enhanced Endotoxin Detection in pharmaceuticals and for medical device testing
Endotoxin-specificity of EndoZyme® eliminates all false-positive and elevated results seen with LAL due to ß-glucan reactions in the LAL cascade more
EndoLISA®: A New Endotoxin Detection Method
Through specific sample preparation EndoLISA® revolutionizes endotoxin quantification in pharmaceutical and biological products more
Profos AG founded in 2000 is certified according to ISO 9001:2000 and ISO 13485:2003. Profos´ core competency is to exploit the principles of bacteriophage biology for biotechnical, diagnostic and research applications. more
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
